Jonathan C. Salo

Jonathan C. Salo

Surgical Oncology

1021 Morehead Medical Drive
Building 1, Suite 5300
Charlotte, NC 28204

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 29 publications

Patient-reported outcomes in NRG Oncology RTOG 1010: Phase 3 trial evaluating the addition of trastuzumab to trimodality treatment of HER2 overexpressing esophageal adenocarcinoma.

Patient-reported outcomes in NRG Oncology RTOG 1010: Phase 3 trial evaluating the addition of trastuzumab to trimodality treatment of HER2 overexpressing esophageal adenocarcinoma.

Journal: Cancer

Published: June 16, 2025

Malnutrition risk and overall survival at solid tumour diagnosis.

Malnutrition risk and overall survival at solid tumour diagnosis.

Journal: BMJ supportive & palliative care

Published: March 27, 2024

Major Intraoperative Complications during Minimally Invasive Esophagectomy: Experience is a Hard Teacher.

Major Intraoperative Complications during Minimally Invasive Esophagectomy: Experience is a Hard Teacher.

Journal: Annals of surgical oncology

Published: September 28, 2023

Factors Associated with Early Discharge after Non-Emergent Right Colectomy for Colon Cancer: A NSQIP Analysis.

Factors Associated with Early Discharge after Non-Emergent Right Colectomy for Colon Cancer: A NSQIP Analysis.

Journal: Current oncology (Toronto, Ont.)

Published: January 28, 2023

Trastuzumab with trimodality treatment for oesophageal adenocarcinoma with HER2 overexpression (NRG Oncology/RTOG 1010): a multicentre, randomised, phase 3 trial.

Trastuzumab with trimodality treatment for oesophageal adenocarcinoma with HER2 overexpression (NRG Oncology/RTOG 1010): a multicentre, randomised, phase 3 trial.

Journal: The Lancet. Oncology

Published: September 23, 2021

ASO Author Reflections: Esophageal Squamous Cell Carcinoma-Still a Conundrum.

ASO Author Reflections: Esophageal Squamous Cell Carcinoma-Still a Conundrum.

Journal: Annals of surgical oncology

Published: August 26, 2021

Preoperative Muscle Strength Is a Predictor of Outcomes After Esophagectomy.

Preoperative Muscle Strength Is a Predictor of Outcomes After Esophagectomy.

Journal: Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract

Published: June 30, 2021

A multi-institutional validation study of prognostic nomograms for retroperitoneal sarcoma.

A multi-institutional validation study of prognostic nomograms for retroperitoneal sarcoma.

Journal: Journal of surgical oncology

Published: May 31, 2021

Malnutrition risk at solid tumor diagnosis: the malnutrition screening tool in a large US cancer institute.

Malnutrition risk at solid tumor diagnosis: the malnutrition screening tool in a large US cancer institute.

Journal: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer

Published: May 19, 2021

Extremity Soft Tissue Sarcoma: A Multi-Institutional Validation of Prognostic Nomograms.

Extremity Soft Tissue Sarcoma: A Multi-Institutional Validation of Prognostic Nomograms.

Journal: Annals of surgical oncology

Published: April 30, 2021

PET Imaging and Rate of Pathologic Complete Response in Esophageal Squamous Cell Carcinoma.

PET Imaging and Rate of Pathologic Complete Response in Esophageal Squamous Cell Carcinoma.

Journal: Annals of surgical oncology

Published: March 23, 2021

Swallowing dysfunction after minimally invasive oesophagectomy.

Swallowing dysfunction after minimally invasive oesophagectomy.

Journal: BMJ supportive & palliative care

Published: August 06, 2020

Showing 1-12 of 29

Last Updated: 09/26/2026